2021 Revenues ($USD) : $934,241,000
2021 R&D spend : $152,902,000
2021 Number of Employees : 3,000
Fiscal Year End : 12/31/2020
Key People : Damien McDonald, CEO; Stephanie Bolton, president, International; Paul Buckman, president, North America; Matthew Dodds, SVP, corporate development; Marco Dolci, SVP, global operations and R&D; Trui Hebbelinck, chief human resources officer; Ryan Miller, VP, strategy; Bryan Olin, SVP, clinical, quality assurance and regulatory affairs; Alex Shvartsburg, CFO; Keyna Skeffington, SVP, general counsel.

About the company: LivaNova is a U.K.-based company that develops devices for cardiac surgery and neuromodulation. The company was formed in 2015 after a $2.7 billion merger between Cyberonics and Sorin. Although the company sold its heart valve business earlier this year, the company today makes devices for the therapeutic areas of advanced circulatory support, cardiopulmonary, drug-resistant epilepsy, heart failure, difficult-to-treat depression and obstructive sleep apnea.  –DK